🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recently, two new oral P2Y12 antagonists have been approved for clinical us...
Status
Completed
Location
University of Florida
Start Date
2014-03
Trial ID
NCT02016170
Treatments Being Tested
The purpose of this study is to assess safety and efficacy of Ticagrelor ve...
Status
Completed
Location
Asan Medical Center
Start Date
2014-07-05
Trial ID
NCT02094963
Treatments Being Tested
Major heart attacks are caused by a number of factors, the two major of whi...
Status
Completed
Location
The Royal Wolverhampton NHS Trust
Start Date
2016-07-21
Trial ID
NCT02733341
Treatments Being Tested
Cangrelor is a potent intravenous P2Y12 receptor inhibitor with rapid onset...
Status
Completed
Location
Dominick Angiolillo
Start Date
2014-04
Trial ID
NCT02081443
Treatments Being Tested
In the PLATO substudy referring to patients presenting with an ST-elevation...
Status
Completed
Location
Patras University Hospital
Start Date
2013-09
Trial ID
NCT01961856
Treatments Being Tested
Background: The acute coronary syndrome (ACS) is a complication of coronar...
Status
Completed
Location
Medical University of Vienna, Department of Clinical Pharmacology
Start Date
2014-05
Trial ID
NCT02080858
Treatments Being Tested
To demonstrate that patients treated with cangrelor can be directly switche...
Status
Completed
Location
Fletcher Allen Health Care
Start Date
2013-01
Trial ID
NCT01766466
Treatments Being Tested
It is designed to test the hypothesis that high loading dose(360mg) ticagre...
Status
Completed
Location
General Hospital of Chinese People's Armed Police Forces
Start Date
2014-06
Trial ID
NCT01962428
Treatments Being Tested
A multicenter, single arm, open label, Phase IV study to evaluate safety an...
Status
Completed
Location
Research Site
Start Date
2015-04-23
Trial ID
NCT02406248
Treatments Being Tested
Ticagrelor is a new generation antiplatelet agent with higher efficacy as c...
Status
Completed
Location
Centre de Recherche Clinique, HUG, Rue Gabrielle Perret-Gentil 4
Start Date
2014-08
Trial ID
NCT02435563
Treatments Being Tested